nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—QPRT—renal system—cervical cancer	0.0637	0.0844	CbGeAlD
Niacin—QPRT—female reproductive system—cervical cancer	0.051	0.0676	CbGeAlD
Niacin—NNMT—uterine cervix—cervical cancer	0.0321	0.0425	CbGeAlD
Niacin—NNMT—decidua—cervical cancer	0.0306	0.0405	CbGeAlD
Niacin—NNMT—renal system—cervical cancer	0.03	0.0398	CbGeAlD
Niacin—NNMT—endometrium—cervical cancer	0.029	0.0385	CbGeAlD
Niacin—NNMT—mammalian vulva—cervical cancer	0.0281	0.0372	CbGeAlD
Niacin—NNMT—uterus—cervical cancer	0.0267	0.0355	CbGeAlD
Niacin—HCAR2—lymph node—cervical cancer	0.025	0.0332	CbGeAlD
Niacin—NNMT—female reproductive system—cervical cancer	0.024	0.0319	CbGeAlD
Niacin—SLC16A3—epithelium—cervical cancer	0.0221	0.0293	CbGeAlD
Niacin—SLC16A3—uterine cervix—cervical cancer	0.0219	0.0291	CbGeAlD
Niacin—NNMT—female gonad—cervical cancer	0.0219	0.029	CbGeAlD
Niacin—NNMT—vagina—cervical cancer	0.0217	0.0288	CbGeAlD
Niacin—SLC16A3—decidua—cervical cancer	0.0209	0.0277	CbGeAlD
Niacin—SLC16A3—renal system—cervical cancer	0.0205	0.0272	CbGeAlD
Niacin—SLC16A3—endometrium—cervical cancer	0.0198	0.0263	CbGeAlD
Niacin—SLC16A3—uterus—cervical cancer	0.0183	0.0242	CbGeAlD
Niacin—SLC16A3—female reproductive system—cervical cancer	0.0164	0.0218	CbGeAlD
Niacin—SLC16A3—female gonad—cervical cancer	0.0149	0.0198	CbGeAlD
Niacin—NNMT—lymph node—cervical cancer	0.0141	0.0186	CbGeAlD
Niacin—SLC16A1—epithelium—cervical cancer	0.0134	0.0178	CbGeAlD
Niacin—SLC16A1—decidua—cervical cancer	0.0127	0.0168	CbGeAlD
Niacin—SLC16A1—renal system—cervical cancer	0.0125	0.0165	CbGeAlD
Niacin—SLC16A1—endometrium—cervical cancer	0.012	0.016	CbGeAlD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.0115	0.0961	CbGpPWpGaD
Niacin—SLC16A1—uterus—cervical cancer	0.0111	0.0147	CbGeAlD
Niacin—SLCO2B1—decidua—cervical cancer	0.0109	0.0145	CbGeAlD
Niacin—SLCO2B1—renal system—cervical cancer	0.0107	0.0142	CbGeAlD
Niacin—SLC16A1—female reproductive system—cervical cancer	0.00998	0.0132	CbGeAlD
Niacin—SLC16A3—lymph node—cervical cancer	0.00961	0.0127	CbGeAlD
Niacin—SLCO2B1—uterus—cervical cancer	0.00955	0.0127	CbGeAlD
Niacin—SLC16A1—female gonad—cervical cancer	0.00908	0.012	CbGeAlD
Niacin—Heartburn—Topotecan—cervical cancer	0.00904	0.0715	CcSEcCtD
Niacin—Lung disorder—Topotecan—cervical cancer	0.00879	0.0696	CcSEcCtD
Niacin—SLCO2B1—female reproductive system—cervical cancer	0.00858	0.0114	CbGeAlD
Niacin—SLCO2B1—female gonad—cervical cancer	0.00781	0.0104	CbGeAlD
Niacin—SLC22A5—uterine cervix—cervical cancer	0.00761	0.0101	CbGeAlD
Niacin—SLC22A5—renal system—cervical cancer	0.00712	0.00944	CbGeAlD
Niacin—SLC22A5—endometrium—cervical cancer	0.00688	0.00912	CbGeAlD
Niacin—Hyperbilirubinaemia—Topotecan—cervical cancer	0.00684	0.0541	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.0062	0.0519	CbGpPWpGaD
Niacin—SLC16A1—lymph node—cervical cancer	0.00584	0.00774	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00583	0.0488	CbGpPWpGaD
Niacin—SLC22A5—female reproductive system—cervical cancer	0.0057	0.00756	CbGeAlD
Niacin—Rash maculo-papular—Topotecan—cervical cancer	0.00566	0.0448	CcSEcCtD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00555	0.0465	CbGpPWpGaD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00552	0.0462	CbGpPWpGaD
Niacin—SLC22A5—female gonad—cervical cancer	0.00519	0.00688	CbGeAlD
Niacin—SLC22A5—vagina—cervical cancer	0.00515	0.00684	CbGeAlD
Niacin—SLCO2B1—lymph node—cervical cancer	0.00502	0.00666	CbGeAlD
Niacin—Dermatitis bullous—Topotecan—cervical cancer	0.00473	0.0374	CcSEcCtD
Niacin—CYP2D6—renal system—cervical cancer	0.00459	0.00609	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—TAAR6—cervical cancer	0.00444	0.0371	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—TAAR6—cervical cancer	0.00421	0.0352	CbGpPWpGaD
Niacin—CYP2D6—female reproductive system—cervical cancer	0.00368	0.00488	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—WNT2—cervical cancer	0.00346	0.029	CbGpPWpGaD
Niacin—Stomatitis—Topotecan—cervical cancer	0.00339	0.0268	CcSEcCtD
Niacin—CYP2D6—female gonad—cervical cancer	0.00335	0.00444	CbGeAlD
Niacin—Sweating—Topotecan—cervical cancer	0.00334	0.0264	CcSEcCtD
Niacin—SLC22A5—lymph node—cervical cancer	0.00333	0.00442	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—WNT2—cervical cancer	0.00328	0.0275	CbGpPWpGaD
Niacin—Haemoglobin—Topotecan—cervical cancer	0.00314	0.0249	CcSEcCtD
Niacin—Rhinitis—Topotecan—cervical cancer	0.00313	0.0248	CcSEcCtD
Niacin—Haemorrhage—Topotecan—cervical cancer	0.00312	0.0247	CcSEcCtD
Niacin—SLC16A3—Hemostasis—GP6—cervical cancer	0.00311	0.026	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—SERPIND1—cervical cancer	0.00311	0.026	CbGpPWpGaD
Niacin—Hypoaesthesia—Topotecan—cervical cancer	0.00311	0.0246	CcSEcCtD
Niacin—Angiopathy—Topotecan—cervical cancer	0.00284	0.0224	CcSEcCtD
Niacin—Chills—Topotecan—cervical cancer	0.0028	0.0222	CcSEcCtD
Niacin—Alopecia—Topotecan—cervical cancer	0.00276	0.0218	CcSEcCtD
Niacin—Malnutrition—Topotecan—cervical cancer	0.00272	0.0215	CcSEcCtD
Niacin—SLC16A3—Hemostasis—GP5—cervical cancer	0.00272	0.0228	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—WNT5A—cervical cancer	0.00263	0.022	CbGpPWpGaD
Niacin—Muscle spasms—Topotecan—cervical cancer	0.00262	0.0207	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—TAAR6—cervical cancer	0.00251	0.021	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—WNT5A—cervical cancer	0.00249	0.0208	CbGpPWpGaD
Niacin—Angioedema—Topotecan—cervical cancer	0.00249	0.0197	CcSEcCtD
Niacin—Leukopenia—Topotecan—cervical cancer	0.00243	0.0193	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—TAAR6—cervical cancer	0.00238	0.0199	CbGpPWpGaD
Niacin—Cough—Topotecan—cervical cancer	0.00237	0.0188	CcSEcCtD
Niacin—Myalgia—Topotecan—cervical cancer	0.00232	0.0183	CcSEcCtD
Niacin—Arthralgia—Topotecan—cervical cancer	0.00232	0.0183	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0023	0.0182	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—TAAR6—cervical cancer	0.00228	0.0191	CbGpPWpGaD
Niacin—Anaphylactic shock—Topotecan—cervical cancer	0.00222	0.0176	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—TAAR6—cervical cancer	0.00216	0.0181	CbGpPWpGaD
Niacin—Skin disorder—Topotecan—cervical cancer	0.00216	0.0171	CcSEcCtD
Niacin—Hyperhidrosis—Topotecan—cervical cancer	0.00215	0.017	CcSEcCtD
Niacin—Anorexia—Topotecan—cervical cancer	0.00212	0.0167	CcSEcCtD
Niacin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00202	0.016	CcSEcCtD
Niacin—Paraesthesia—Topotecan—cervical cancer	0.00199	0.0158	CcSEcCtD
Niacin—Dyspnoea—Topotecan—cervical cancer	0.00198	0.0157	CcSEcCtD
Niacin—Dyspepsia—Topotecan—cervical cancer	0.00195	0.0155	CcSEcCtD
Niacin—Decreased appetite—Topotecan—cervical cancer	0.00193	0.0153	CcSEcCtD
Niacin—Gastrointestinal disorder—Topotecan—cervical cancer	0.00192	0.0152	CcSEcCtD
Niacin—Pain—Topotecan—cervical cancer	0.0019	0.015	CcSEcCtD
Niacin—Gastrointestinal pain—Topotecan—cervical cancer	0.00182	0.0144	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—WNT2—cervical cancer	0.00178	0.0149	CbGpPWpGaD
Niacin—Urticaria—Topotecan—cervical cancer	0.00176	0.014	CcSEcCtD
Niacin—Abdominal pain—Topotecan—cervical cancer	0.00176	0.0139	CcSEcCtD
Niacin—Body temperature increased—Topotecan—cervical cancer	0.00176	0.0139	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—AKAP13—cervical cancer	0.00172	0.0144	CbGpPWpGaD
Niacin—QPRT—Disease—WNT2—cervical cancer	0.00172	0.0144	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—WNT2—cervical cancer	0.00169	0.0141	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GP6—cervical cancer	0.00168	0.0141	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPIND1—cervical cancer	0.00168	0.0141	CbGpPWpGaD
Niacin—Hypersensitivity—Topotecan—cervical cancer	0.00164	0.0129	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—AKAP13—cervical cancer	0.00163	0.0136	CbGpPWpGaD
Niacin—Asthenia—Topotecan—cervical cancer	0.00159	0.0126	CcSEcCtD
Niacin—Pruritus—Topotecan—cervical cancer	0.00157	0.0124	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—AKAP13—cervical cancer	0.00156	0.0131	CbGpPWpGaD
Niacin—Diarrhoea—Topotecan—cervical cancer	0.00152	0.012	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—AKAP13—cervical cancer	0.00148	0.0124	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—GP5—cervical cancer	0.00147	0.0123	CbGpPWpGaD
Niacin—Dizziness—Topotecan—cervical cancer	0.00147	0.0116	CcSEcCtD
Niacin—Vomiting—Topotecan—cervical cancer	0.00141	0.0112	CcSEcCtD
Niacin—Rash—Topotecan—cervical cancer	0.0014	0.0111	CcSEcCtD
Niacin—Dermatitis—Topotecan—cervical cancer	0.0014	0.0111	CcSEcCtD
Niacin—Headache—Topotecan—cervical cancer	0.00139	0.011	CcSEcCtD
Niacin—QPRT—Metabolism—CA9—cervical cancer	0.00136	0.0114	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—WNT5A—cervical cancer	0.00135	0.0113	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TAAR6—cervical cancer	0.00135	0.0113	CbGpPWpGaD
Niacin—Nausea—Topotecan—cervical cancer	0.00132	0.0104	CcSEcCtD
Niacin—QPRT—Disease—WNT5A—cervical cancer	0.0013	0.0109	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—WNT5A—cervical cancer	0.00128	0.0107	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TAAR6—cervical cancer	0.00128	0.0107	CbGpPWpGaD
Niacin—NNMT—Metabolism—CA9—cervical cancer	0.00126	0.0106	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—WNT2—cervical cancer	0.00105	0.00879	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—WNT2—cervical cancer	0.000996	0.00833	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKAP13—cervical cancer	0.000922	0.00772	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKAP13—cervical cancer	0.000874	0.00732	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—WNT5A—cervical cancer	0.000796	0.00666	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—WNT5A—cervical cancer	0.000754	0.00632	CbGpPWpGaD
Niacin—QPRT—Disease—HES1—cervical cancer	0.000748	0.00626	CbGpPWpGaD
Niacin—QPRT—Disease—MTHFR—cervical cancer	0.000657	0.0055	CbGpPWpGaD
Niacin—QPRT—Disease—TERT—cervical cancer	0.000656	0.00549	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CA9—cervical cancer	0.000616	0.00516	CbGpPWpGaD
Niacin—QPRT—Disease—FGFR3—cervical cancer	0.000602	0.00504	CbGpPWpGaD
Niacin—QPRT—Disease—NOTCH1—cervical cancer	0.000565	0.00473	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH2—cervical cancer	0.000559	0.00468	CbGpPWpGaD
Niacin—QPRT—Metabolism—MTHFR—cervical cancer	0.000551	0.00461	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH2—cervical cancer	0.00053	0.00443	CbGpPWpGaD
Niacin—NNMT—Metabolism—MTHFR—cervical cancer	0.000512	0.00429	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HES1—cervical cancer	0.000458	0.00383	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HES1—cervical cancer	0.000434	0.00363	CbGpPWpGaD
Niacin—QPRT—Disease—MTOR—cervical cancer	0.000423	0.00354	CbGpPWpGaD
Niacin—QPRT—Disease—CD4—cervical cancer	0.000422	0.00354	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TERT—cervical cancer	0.000401	0.00336	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TERT—cervical cancer	0.00038	0.00318	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—cervical cancer	0.000375	0.00314	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—FGFR3—cervical cancer	0.000368	0.00308	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—FGFR3—cervical cancer	0.000349	0.00292	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH1—cervical cancer	0.000346	0.00289	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CA9—cervical cancer	0.000333	0.00278	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH1—cervical cancer	0.000328	0.00274	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—cervical cancer	0.000327	0.00274	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—cervical cancer	0.000308	0.00258	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—cervical cancer	0.000297	0.00249	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—cervical cancer	0.000292	0.00244	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—cervical cancer	0.000259	0.00217	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—cervical cancer	0.00025	0.00209	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—cervical cancer	0.000246	0.00206	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—cervical cancer	0.000238	0.00199	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—cervical cancer	0.000234	0.00196	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—cervical cancer	0.00023	0.00192	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—cervical cancer	0.000226	0.00189	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—cervical cancer	0.000218	0.00182	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—cervical cancer	0.0002	0.00168	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—cervical cancer	0.00019	0.00159	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—cervical cancer	0.000182	0.00152	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—cervical cancer	0.000173	0.00144	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—cervical cancer	0.000153	0.00128	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—cervical cancer	0.000145	0.00121	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—cervical cancer	0.000135	0.00113	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—cervical cancer	0.000126	0.00106	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA9—cervical cancer	9.27e-05	0.000776	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—cervical cancer	3.76e-05	0.000315	CbGpPWpGaD
